• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 作为胶质瘤诊断的潜在生物标志物:系统评价和荟萃分析。

MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.

机构信息

Department of Neurosurgery and Shenzhen Key Laboratory of Neurosurgery, Shenzhen University 1st Affiliated Hospital, Shenzhen Second People's Hospital, Shenzhen, China.

Department of Clinical Medicine College, Anhui Medical University, Hefei, China.

出版信息

Cancer Sci. 2018 Sep;109(9):2651-2659. doi: 10.1111/cas.13714. Epub 2018 Aug 3.

DOI:10.1111/cas.13714
PMID:29949235
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6125451/
Abstract

Glioma is the most common central nervous system tumor and associated with poor prognosis. Identifying effective diagnostic biomarkers for glioma is particularly important in order to guide optimizing treatment. MicroRNAs (miRNAs) have drawn much attention because of their diagnostic value in diverse cancers, including glioma. We summarized studies to identify the potential diagnostic values of miRNAs in glioma patients. We included articles reporting miRNAs for differentiation of glioma patients from controls. We calculated sensitivities, specificities, and area under the curves (AUC) of individual miRNA and miRNA panels. We found that overall sensitivity, specificity, and AUC of miRNAs in diagnosis of glioma were 85% (95% confidence interval [CI]: 0.81-0.89), 90% (95% CI 0.85-0.93), and 93% (95% CI 0.91-0.95), respectively. Meta-regression analysis showed that the detection of miRNAs expression in cerebrospinal fluid (CSF) and brain tissue largely improved the diagnostic accuracy. Likewise, panels of multiple miRNAs could enhance the pooled sensitivity. Moreover, AUC of miR-21 was 0.88, with 86% sensitivity and 94% specificity. This study demonstrated that miRNAs could function as potential diagnosis markers in glioma. Detection of miRNAs in CSF and brain tissue displays high accuracy in the diagnosis of glioma.

摘要

脑胶质瘤是最常见的中枢神经系统肿瘤,预后不良。因此,寻找有效的脑胶质瘤诊断生物标志物对于指导优化治疗尤为重要。微小 RNA(miRNA)因其在多种癌症(包括脑胶质瘤)中的诊断价值而备受关注。我们总结了旨在确定 miRNA 对脑胶质瘤患者诊断价值的研究。我们纳入了报道 miRNA 可区分脑胶质瘤患者和对照的文章。我们计算了单个 miRNA 和 miRNA 组合的灵敏度、特异度和曲线下面积(AUC)。结果发现,miRNA 对脑胶质瘤的总体诊断灵敏度、特异度和 AUC 分别为 85%(95%CI:0.81-0.89)、90%(95%CI:0.85-0.93)和 93%(95%CI:0.91-0.95)。Meta 回归分析表明,脑脊液(CSF)和脑组织中 miRNA 表达的检测极大地提高了诊断准确性。同样,多个 miRNA 的组合也可以提高合并灵敏度。此外,miR-21 的 AUC 为 0.88,灵敏度为 86%,特异度为 94%。本研究表明,miRNA 可以作为脑胶质瘤潜在的诊断标志物。CSF 和脑组织中 miRNA 的检测在脑胶质瘤的诊断中具有较高的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/58a3cdb483d8/CAS-109-2651-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/eddd58d0f098/CAS-109-2651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/c41a7377bfff/CAS-109-2651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/3b32522df10f/CAS-109-2651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/59c937844bcd/CAS-109-2651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/58a3cdb483d8/CAS-109-2651-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/eddd58d0f098/CAS-109-2651-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/c41a7377bfff/CAS-109-2651-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/3b32522df10f/CAS-109-2651-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/59c937844bcd/CAS-109-2651-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a417/6125451/58a3cdb483d8/CAS-109-2651-g005.jpg

相似文献

1
MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis.微小 RNA 作为胶质瘤诊断的潜在生物标志物:系统评价和荟萃分析。
Cancer Sci. 2018 Sep;109(9):2651-2659. doi: 10.1111/cas.13714. Epub 2018 Aug 3.
2
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
5
MicroRNAs as biomarkers in spontaneous intracerebral hemorrhage: A systematic review of recent clinical evidence.微小 RNA 作为自发性脑出血的生物标志物:近期临床证据的系统评价。
Clin Neurol Neurosurg. 2022 Feb;213:107130. doi: 10.1016/j.clineuro.2022.107130. Epub 2022 Jan 14.
6
Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.循环 microRNAs 作为乳腺癌潜在诊断生物标志物的研究:系统综述和荟萃分析。
Breast Cancer Res Treat. 2022 Nov;196(1):1-15. doi: 10.1007/s10549-022-06728-8. Epub 2022 Sep 9.
7
Thoracic imaging tests for the diagnosis of COVID-19.用于 COVID-19 诊断的胸部影像学检查。
Cochrane Database Syst Rev. 2022 May 16;5(5):CD013639. doi: 10.1002/14651858.CD013639.pub5.
8
lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.长链非编码 RNA 作为胶质瘤临床病理和预后的潜在分子标志物:系统评价和荟萃分析。
Gene. 2018 Aug 20;668:77-86. doi: 10.1016/j.gene.2018.05.054. Epub 2018 May 17.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Duplex ultrasound for diagnosing symptomatic carotid stenosis in the extracranial segments.双功能超声用于诊断颅外段有症状颈动脉狭窄。
Cochrane Database Syst Rev. 2022 Jul 11;7(7):CD013172. doi: 10.1002/14651858.CD013172.pub2.

引用本文的文献

1
Inducer microRNAs in the glioma development: a concise review of mechanisms and insights into targeted therapy.胶质瘤发生中的诱导性微小RNA:机制简述及靶向治疗见解
J Egypt Natl Canc Inst. 2025 Aug 18;37(1):55. doi: 10.1186/s43046-025-00308-9.
2
Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing.应用下一代RNA测序技术鉴定参与肿瘤发生的失调miRNA和mRNA并检测胶质母细胞瘤患者
Pharmaceuticals (Basel). 2025 Mar 19;18(3):431. doi: 10.3390/ph18030431.
3
Diagnostics and Therapy for Malignant Tumors.

本文引用的文献

1
A comprehensive meta-analysis of circulation miRNAs in glioma as potential diagnostic biomarker.胶质瘤中循环微小RNA作为潜在诊断生物标志物的综合荟萃分析。
PLoS One. 2018 Feb 14;13(2):e0189452. doi: 10.1371/journal.pone.0189452. eCollection 2018.
2
Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response.胶质母细胞瘤和烷基化剂化疗耐药:细胞凋亡、自噬和未折叠蛋白反应的参与。
Pharmacol Ther. 2018 Apr;184:13-41. doi: 10.1016/j.pharmthera.2017.10.017. Epub 2017 Nov 8.
3
Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
恶性肿瘤的诊断与治疗
Biomedicines. 2024 Nov 21;12(12):2659. doi: 10.3390/biomedicines12122659.
4
Meta-analysis of the diagnostic value of exosomal microRNAs in renal cell carcinoma.肾细胞癌中外泌体微小RNA诊断价值的Meta分析
Front Oncol. 2024 Oct 28;14:1441429. doi: 10.3389/fonc.2024.1441429. eCollection 2024.
5
The Correlation Patterns of miRNA Expression with Targeted mRNA Transcripts in Glioma Patients with Wild-Type and Mutated Isocitrate Dehydrogenase (IDH) Genotypes.野生型和异柠檬酸脱氢酶(IDH)基因突变型胶质瘤患者中miRNA表达与靶向mRNA转录本的相关性模式
Acta Naturae. 2024 Jul-Sep;16(3):38-45. doi: 10.32607/actanaturae.27363.
6
MiR-155-5p regulates autophagy and apoptosis of glioma cells through RICTOR.微小RNA-155-5p通过雷帕霉素靶蛋白相互作用蛋白调控胶质瘤细胞的自噬和凋亡。
Transl Cancer Res. 2024 Oct 31;13(10):5509-5521. doi: 10.21037/tcr-24-543. Epub 2024 Oct 18.
7
MicroRNAs as Biomarkers of Brain Tumor.微小RNA作为脑肿瘤的生物标志物
Cancer Manag Res. 2024 Oct 4;16:1353-1361. doi: 10.2147/CMAR.S484158. eCollection 2024.
8
The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives.基于微小RNA的方法在胶质母细胞瘤中的潜力:当前进展与未来展望的最新情况
Curr Res Pharmacol Drug Discov. 2024 Jun 29;7:100193. doi: 10.1016/j.crphar.2024.100193. eCollection 2024.
9
The Multifaceted Role of miR-21 in Pancreatic Cancers.miR-21 在胰腺癌细胞中的多效作用。
Cells. 2024 May 30;13(11):948. doi: 10.3390/cells13110948.
10
Post-stroke cognitive impairment: exploring molecular mechanisms and omics biomarkers for early identification and intervention.中风后认知障碍:探索早期识别与干预的分子机制和组学生物标志物
Front Mol Neurosci. 2024 May 23;17:1375973. doi: 10.3389/fnmol.2024.1375973. eCollection 2024.
血清外泌体 miR-301a 作为人类神经胶质瘤潜在的诊断和预后生物标志物。
Cell Oncol (Dordr). 2018 Feb;41(1):25-33. doi: 10.1007/s13402-017-0355-3. Epub 2017 Oct 26.
4
A microRNA signature from serum exosomes of patients with glioma as complementary diagnostic biomarker.血清外泌体中的 microRNA 特征作为胶质细胞瘤患者的补充诊断生物标志物。
J Neurooncol. 2018 Jan;136(1):51-62. doi: 10.1007/s11060-017-2639-x. Epub 2017 Oct 26.
5
A cerebrospinal fluid microRNA signature as biomarker for glioblastoma.一种作为胶质母细胞瘤生物标志物的脑脊液微小RNA特征
Oncotarget. 2017 Jun 1;8(40):68769-68779. doi: 10.18632/oncotarget.18332. eCollection 2017 Sep 15.
6
Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma.循环 microRNA-203 减少预示胶质母细胞瘤预后不良。
Cancer Biomark. 2017 Dec 6;20(4):521-526. doi: 10.3233/CBM-170335.
7
Pilot Study of Whole Blood MicroRNAs as Potential Tools for Diffuse Low-Grade Gliomas Detection.全血 microRNAs 作为弥漫性低级别神经胶质瘤检测潜在工具的初步研究。
Cell Mol Neurobiol. 2018 Apr;38(3):715-725. doi: 10.1007/s10571-017-0536-7. Epub 2017 Aug 16.
8
Insights From Molecular Profiling of Adult Glioma.成人脑胶质瘤的分子分析研究进展
J Clin Oncol. 2017 Jul 20;35(21):2386-2393. doi: 10.1200/JCO.2017.73.9516. Epub 2017 Jun 22.
9
Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.血浆miR-122作为人类胶质瘤潜在的诊断和预后指标。
Neurol Sci. 2017 Jun;38(6):1087-1092. doi: 10.1007/s10072-017-2912-y. Epub 2017 Apr 3.
10
Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas.血清微小RNA-376家族作为人类胶质瘤的诊断和预后标志物
Cancer Biomark. 2017;19(2):137-144. doi: 10.3233/CBM-160146.